PolyNovo Limited provided unaudited revenues results for the first half 2023. The company record first half 2023 sales of AUD 27.3 million up 67.5% on STLY of AUD 16.3 million. Total revenue including BARDA was AUD 29.5 million up 62.2% on STLY of AUD 18.2 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 AUD | -4.78% | +2.31% | +20.24% |
Mar. 04 | Polynovo Gets India OK for Listing of Dermal Scaffold Device on Government e-Portal Marketplace | MT |
Feb. 27 | Transcript : PolyNovo Limited, H1 2024 Earnings Call, Feb 27, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.24% | 896M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- PNV Stock
- News PolyNovo Limited
- PolyNovo Limited Provides Unaudited Revenues Results for the First Half 2023